Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin

Neuropeptides

Volumn 45, Issue 3, 2011, Pages 229-237

  Engel, Matthias A ^a   Izydorczyk, Iwona ^a   Mueller Tribbensee, Sonja M ^a   Becker, Christoph ^a   Neurath, Markus F ^a   Reeh, Peter W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

9 THC; AM 251; Anandamide; BCTC; Capsaicin; Desensitization; Nociception; Primary afferent neurons

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CAPSAICIN; TETRAHYDROCANNABINOL; VANILLOID RECEPTOR 1;

ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; GENE EXPRESSION; HEAT SENSITIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RODENT; SKIN;

ANIMALS; ARACHIDONIC ACIDS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; HOT TEMPERATURE; MALE; MICE; MICE, KNOCKOUT; POLYUNSATURATED ALKAMIDES; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SENSORY SYSTEM AGENTS; SKIN; TETRAHYDROCANNABINOL; TRPV CATION CHANNELS;

MUS; RATTUS; RODENTIA;

EID: 79955639903     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2011.03.005     Document Type: Article

References (34)

1. Abrams D.I., Jay C.A., Shade S.B., Vizoso H., Reda H., Press S., Kelly M.E., Rowbotham M.C., Petersen K.L. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 2007, 68:515-521.
2. Abrams D.I., Vizoso H.P., Shade S.B., Jay C., Kelly M.E., Benowitz N.L. Vaporization as a smokeless cannabis delivery system: a pilot study. Clin. Pharmacol. Ther. 2007, 82:572-578.
3. Agarwal N., Pacher P., Tegeder I., Amaya F., Constantin C.E., Brenner G.J., Rubino T., Michalski C.W., Marsicano G., Monory K., Mackie K., Marian C., Batkai S., Parolaro D., Fischer M.J., Reeh P., Kunos G., Kress M., Lutz B., Woolf C.J., Kuner R. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 2007, 10:870-879.
4. Ahluwalia J., Urban L., Capogna M., Bevan S., Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 2000, 100:685-688.
5. Akopian A.N., Ruparel N.B., Jeske N.A., Patwardhan A., Hargreaves K.M. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol. Sci. 2009, 30:79-84.
6. Averbeck B., Reeh P.W., Michaelis M. Modulation of CGRP and PGE2 release from isolated rat skin by alpha-adrenoceptors and kappa-opioid-receptors. Neuroreport 2001, 12:2097-2100.
7. Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R., Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 1995, 375:143-147.
8. Bernardini N., Roza C., Sauer S.K., Gomeza J., Wess J., Reeh P.W. Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception. J. Neurosci. 2002, 22:229.
9. Bishay P., Schmidt H., Marian C., Häussler A., Wijnvoord N., Ziebell S., Metzner J., Koch M., Myrczek T., Bechmann I., Kuner R., Costigan M., Dehghani F., Geisslinger G., Tegeder I. R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One 2010, 5:10628.
10. Bretag A.H. Synthetic interstitial fluid for isolated mammalian tissue. Life Sci. 1969, 8:319-329.
11. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313.
12. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405:183-187.
13. Derow A., Izydorczyk I., Kuhn A., Reeh P.W., Petho G. Prostaglandin E(2) and I(2) facilitate noxious heat-induced spike discharge but not iCGRP release from rat cutaneous nociceptors. Life Sci. 2007, 81:1685-1693.
14. Fioravanti B., De F.M., Stucky C.L., Medler K.A., Luo M.C., Gardell L.R., Ibrahim M., Malan T.P.Jr., Yamamura H.I., Ossipov M.H., King T., Lai J., Porreca F., Vanderah T.W. Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J. Neurosci. 2008, 28:11593-11602.
15. Fischer M.J., Reeh P.W. Sensitization to heat through G-protein-coupled receptor pathways in the isolated sciatic mouse nerve. Eur. J. Neurosci. 2007, 25:3570-3575.
16. Frank B., Serpell M.G., Hughes J., Matthews J.N., Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ 2008, 336:199-201.
17. Hegyi Z., Kis G., Holló K., Ledent C., Antal M. Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord. Eur. J. Neurosci. 2009, 30:251-262.
18. Jordt S.E., Bautista D.M., Chuang H.H., McKemy D.D., Zygmunt P.M., Högestätt E.D., Meng I.D., Julius D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004, 427:260-265.
19. Kessler F., Habelt C., Averbeck B., Reeh P.W., Kress M. Heat-induced release of CGRP from isolated rat skin and effects of bradykinin and the protein kinase C activator PMA. Pain 1999, 83:289-295.
20. Kichko T.I., Reeh P.W. TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea. Eur. J. Neurosci. 2009, 29:1896-1904.
21. Nemeth J., Helyes Z., Than M., Jakab B., Pinter E., Szolcsanyi J. Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae. Neurosci. Lett. 2003, 336:89-92.
22. Patwardhan A.M., Jeske N.A., Price T.J., Gamper N., Akopian A.N., Hargreaves K.M. The cannabinoid WIN 55, 212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc. Natl. Acad. Sci. USA. 2006, 103:11393-11398.
23. Price T.J., Patwardhan A., Akopian A.N., Hargreaves K.M., Flores C.M. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br. J. Pharmacol. 2004, 141:1118-1130.
24. Rathee P.K., Distler C., Obreja O., Neuhuber W., Wang G.K., Wang S.Y., Nau C., Kress M. PKA/AKAP/VR-1 module: A common link of Gs-mediated signaling to thermal hyperalgesia. J. Neurosci. 2002, 22:4740-4745.
25. Richardson J.D., Kilo S., Hargreaves K.M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 1998, 75:111-119.
26. Schley M., Legler A., Skopp G., Schmelz M., Konrad C., Rukwied R. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr. Med. Res. Opin. 2006, 22:1269-1276.
27. Singh Tahim A., Sántha P., Nagy I. Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience 2005, 136:539-548.
28. Spitzer M.J., Reeh P.W., Sauer S.K. Mechanisms of potassium- and capsaicin-induced axonal calcitonin gene-related peptide release: involvement of L- and T-type calcium channels and TRPV1 but not sodium channels. Neuroscience 2008, 151:836-842.
29. Szolcsanyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 2004, 38:377-384.
30. Touska F., Marsakova L., Teisinger J., Vlachova V. A " cute" desensitization of TRPV1. Curr. Pharm. Biotechnol. 2011, 12:122-129.
31. Zeilhofer H.U. Spinal cannabinoids-a double-edged sword?. Eur. J. Neurosci. 2010, 31:223-224. (Commentary on Zhang et al.).
32. Zhang G., Chen W., Lao L., Marvizón J.C. Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization. Eur. J. Neurosci. 2010, 31:225-237.
33. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U S A 1999, 96:5780-5785.
34. Zimmermann K., Leffler A., Fischer M.M., Messlinger K., Nau C., Reeh P.W. The TRPV1/2/3 activator 2-aminoethoxydiphenyl borate sensitizes native nociceptive neurons to heat in wildtype but not TRPV1 deficient mice. Neuroscience 2005, 135:1277-1284.